CAS – STN IP Protection Suite: Synergising innovation and protection
In today’s fast-moving pharma landscape, innovation without protection is a missed opportunity.
Therefore, CAS, a division of…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Gerresheimer to separate moulded glass and intends to initiate a subsequent sales process
Further step in Gerresheimer's strategic transformation into a system and solution provider purely for the pharma and biotech…
Nanoscope Therapeutics’ MCO-010 holds potential to become new treatment option for retinitis:…
GlobalData outlines how Nanoscope’s BLA submission for MCO-010 underscores a possible shift in the retinitis pigmentosa treatment…
Zenara Pharma receives US FDA approval for generic Sertraline Hydrochloride Capsules
FDA grants Zenara 180-day marketing exclusivity for first generic version of Almatica Pharma’s Sertraline Hydrochloride Capsules
Concept Medical announces first patient enrolment in MAGICAL-SV IDE trial
The trial evaluates the MagicTouch Sirolimus-Coated Balloon (SCB) against drug-eluting stents in the treatment of small coronary…
Eli Lilly launches new technology and innovation site in Hyderabad
The Hyderabad site will serve as a strategic digital operations centre for Eli Lilly, focusing on AI, cloud, and automation, with…
India’s pharma funding reaches $294 million in July 2025
Pharma funding snapshot highlights late-stage dominance and surge in capital flow, with Meril’s $200M round leading July’s…
US-EU trade deal puts pharma industry at substantial fiscal risk: GlobalData
The imposition of tariffs threatens to elevate costs, creating uncertainty in launch planning, particularly for late-stage assets…
Lilly’s Mounjaro (tirzepatide) demonstrated cardiovascular protection in a head-to-head trial
Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8 per cent lower rate of MACE-3 events, while…
Touchlight introduces mbDNA: A circular single-stranded DNA (ssDNA) platform enabling superior gene…
mbDNA’s design supports 1-20kb gene insertions and aims to offer more knock-in efficiency across diverse cell types